Status:
COMPLETED
National Evaluation of PI-based 2nd Line Efficacy in Cambodia
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
Medium and long term efficacy of PI-based 2nd line antiretroviral (ARV) therapy in Cambodia is poorly documented when the numbers of patients on treatment and their duration are increasing. For patien...
Eligibility Criteria
Inclusion
- HIV infection
- age above 18 years
- current PI based 2nd line ARV treatment since at least 6 months
- willing to participate and consent signature
Exclusion
- ongoing PI based 2nd line regimen for less that 6 months at time of study intake
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
15001351 Patients enrolled
Trial Details
Trial ID
NCT01801618
Start Date
February 1 2013
End Date
December 1 2014
Last Update
July 21 2016
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Battambang Hospital
Battambang, Cambodia
2
Chey Chum Neah Hospital
Chey Chum Neah, Cambodia
3
Daun Keo Hospital
Daun Keo, Cambodia
4
Kampong Cham Hospital
Kampong Cham, Cambodia